Terms: = Prostate cancer AND ITK, PSCTK2, 3702, Q08881, ENSG00000113263, EMT, MGC126258, LYK, MGC126257 AND Diagnosis
37 results:
1. Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesions.
Mei S; Alchahin AM; Tsea I; Kfoury Y; Hirz T; Jeffries NE; Zhao T; Xu Y; Zhang H; Sarkar H; Wu S; Subtelny AO; Johnsen JI; Zhang Y; Salari K; Wu CL; Randolph MA; Scadden DT; Dahl DM; Shin J; Kharchenko PV; Saylor PJ; Sykes DB; Baryawno N
Genome Med; 2024 Jan; 16(1):1. PubMed ID: 38281962
[TBL] [Abstract] [Full Text] [Related]
2. Co-expression of Twist and Snai1: predictor of poor prognosis and biomarker of treatment resistance in untreated prostate cancer.
Said R; Hernández-Losa J; Moline T; de Haro RSL; Zouari S; Blel A; Rammeh S; Derouiche A; Ouerhani S
Mol Biol Rep; 2024 Jan; 51(1):226. PubMed ID: 38281235
[TBL] [Abstract] [Full Text] [Related]
3. Small extracellular vesicles: Non-negligible vesicles in tumor progression, diagnosis, and therapy.
Zhou X; Jia Y; Mao C; Liu S
Cancer Lett; 2024 Jan; 580():216481. PubMed ID: 37972701
[TBL] [Abstract] [Full Text] [Related]
4. Construction of lncRNA/Pseudogene-miRNA Network Based on In Silico Approaches for Glycolysis Pathway to Identify prostate Adenocarcinoma-Related Potential Biomarkers.
Khorsand M; Mostafavi-Pour Z; Tahmasebi A; Omidvar Kordshouli S; Mousavi P
Appl Biochem Biotechnol; 2024 Apr; 196(4):2332-2355. PubMed ID: 37542606
[TBL] [Abstract] [Full Text] [Related]
5. FTIR microspectroscopy and multivariate analysis facilitate identification of dynamic changes in epithelial-to-mesenchymal transition induced by TGF-β in prostate cancer cells.
Karmakar D; Lahiri P; Bedi M; Ghosh A; Ghosh A; Barui A; Varshney SK; Lahiri B; Sengupta S
J Cell Biochem; 2023 Jun; 124(6):849-860. PubMed ID: 37158093
[TBL] [Abstract] [Full Text] [Related]
6. Potent carotenoid astaxanthin expands the anti-cancer activity of cisplatin in human prostate cancer cells.
Erzurumlu Y; Catakli D; Dogan HK
J Nat Med; 2023 Jun; 77(3):572-583. PubMed ID: 37130999
[TBL] [Abstract] [Full Text] [Related]
7. HP1α promotes the progression of prostate cancer.
Zhang S; Li H; Shen C; Cao F; Kang S
Mol Biol Rep; 2023 May; 50(5):4459-4468. PubMed ID: 37014569
[TBL] [Abstract] [Full Text] [Related]
8. GOLM1 Promotes Epithelial-Mesenchymal Transition by Activating TGFβ1/Smad2 Signaling in prostate cancer.
Qin X; Liu L; Li Y; Luo H; Chen H; Weng X
Technol Cancer Res Treat; 2023; 22():15330338231153618. PubMed ID: 36999196
[No Abstract] [Full Text] [Related]
9. Pharmacological inhibition of the SKP2/p300 signaling axis restricts castration-resistant prostate cancer.
Rezaeian AH; Phan LM; Zhou X; Wei W; Inuzuka H
Neoplasia; 2023 Apr; 38():100890. PubMed ID: 36871351
[TBL] [Abstract] [Full Text] [Related]
10. Pre-clinical and clinical importance of miR-21 in human cancers: Tumorigenesis, therapy response, delivery approaches and targeting agents.
Hashemi M; Mirdamadi MSA; Talebi Y; Khaniabad N; Banaei G; Daneii P; Gholami S; Ghorbani A; Tavakolpournegari A; Farsani ZM; Zarrabi A; Nabavi N; Zandieh MA; Rashidi M; Taheriazam A; Entezari M; Khan H
Pharmacol Res; 2023 Jan; 187():106568. PubMed ID: 36423787
[TBL] [Abstract] [Full Text] [Related]
11. Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling.
Entezari M; Ghanbarirad M; Taheriazam A; Sadrkhanloo M; Zabolian A; Goharrizi MASB; Hushmandi K; Aref AR; Ashrafizadeh M; Zarrabi A; Nabavi N; Rabiee N; Hashemi M; Samarghandian S
Biomed Pharmacother; 2022 Jun; 150():112963. PubMed ID: 35468579
[TBL] [Abstract] [Full Text] [Related]
12. LINC00963: A potential cancer diagnostic and therapeutic target.
Xie Z; Zhong C; Shen J; Jia Y; Duan S
Biomed Pharmacother; 2022 Jun; 150():113019. PubMed ID: 35462329
[TBL] [Abstract] [Full Text] [Related]
13. Ubiquitin-specific protease 1 overexpression indicates poor prognosis and promotes proliferation, migration, and invasion of gastric cancer cells.
Meng D; Li D
Tissue Cell; 2022 Feb; 74():101723. PubMed ID: 34990966
[TBL] [Abstract] [Full Text] [Related]
14. Mechanisms, diagnosis and Treatment of Bone Metastases.
Ban J; Fock V; Aryee DNT; Kovar H
Cells; 2021 Oct; 10(11):. PubMed ID: 34831167
[TBL] [Abstract] [Full Text] [Related]
15. Dysfunction of miR-802 in tumors.
Gao T; Zou M; Shen T; Duan S
J Clin Lab Anal; 2021 Nov; 35(11):e23989. PubMed ID: 34558723
[TBL] [Abstract] [Full Text] [Related]
16. Long non-coding DANCR targets miR-185-5p to upregulate LIM and SH3 protein 1 promoting prostate cancer via the FAK/PI3K/AKT/GSK3β/snail pathway.
Sun W; Zu S; Shao G; Wang W; Gong F
J Gene Med; 2021 Jul; 23(7):e3344. PubMed ID: 33885171
[TBL] [Abstract] [Full Text] [Related]
17. Cell-free DNA promotes malignant transformation in non-tumor cells.
Souza AG; Bastos VAF; Fujimura PT; Ferreira ICC; Leal LF; da Silva LS; Laus AC; Reis RM; Martins MM; Santos PS; Corrêa NCR; Marangoni K; Thomé CH; Colli LM; Goulart LR; Goulart VA
Sci Rep; 2020 Dec; 10(1):21674. PubMed ID: 33303880
[TBL] [Abstract] [Full Text] [Related]
18. Resveratrol Suppresses prostate cancer Epithelial Cell Scatter/Invasion by Targeting Inhibition of Hepatocyte Growth Factor (HGF) Secretion by prostate Stromal Cells and Upregulation of E-cadherin by prostate cancer Epithelial Cells.
Hsieh TC; Wu JM
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32143478
[TBL] [Abstract] [Full Text] [Related]
19. POTEE promotes colorectal carcinoma progression via activating the Rac1/Cdc42 pathway.
Xu Q; Chen J; Peng M; Duan S; Hu Y; Guo D; Geng J; Zhou J
Exp Cell Res; 2020 May; 390(1):111933. PubMed ID: 32142855
[TBL] [Abstract] [Full Text] [Related]
20. Epithelial-mesenchymal transition of circulating tumor cells in prostate cancer is promoted by survivin.
Yang F; Ma J; Wan J; Ha W; Fang C; Lu H; Zhang W
J Int Med Res; 2020 Jan; 48(1):300060519892395. PubMed ID: 31948306
[TBL] [Abstract] [Full Text] [Related]
[Next]